Breaking News
Get 45% Off 0
🔎 How to spot overhyped stocks (like these) before they drop
Read more

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Zumiez (ZUMZ) Beats Q3 Earnings and Revenue Estimates By Zacks Investment Research - Dec 03, 2020

Zumiez (NASDAQ:ZUMZ) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.75 per share a year ago. These...

Aon's (AON) Solution to Help Businesses Check Cyber Threats By Zacks Investment Research - Dec 03, 2020

Aon plc (NYSE:AON) AON recently introduced a digital cyber insurance solution, which is designed to help small and middle market businesses in purchasing and managing cyber and professional liability...

Oil Stocks: Buy for 2021? By Zacks Investment Research - Dec 02, 2020 1

(0:45) - Energy Industry Booming Rebound(8:35) - Why Should Investors Be Buying Into Energy Stocks?(11:00) - Tracey’s Top Stock Picks(21:25) - Episode Roundup: CVX, XOM, PXD, EOG, COP ...

Five Below (FIVE) Q3 Earnings Beat Estimates, Comps Surge By Zacks Investment Research - Dec 02, 2020

Five Below (NASDAQ:FIVE), Inc. FIVE maintained its stellar performance in third-quarter fiscal 2020, wherein the top and the bottom line not only surpassed the Zacks Consensus Estimate but also...

MGM Resorts (MGM) Divests Stake in MGP to Boost Liquidity By Zacks Investment Research - Dec 02, 2020

Maintaining liquidity has become a herculean task for most of the companies in the current scenario. MGM Resorts (NYSE:MGM) International MGM and MGM Growth Properties (NYSE:MGP) LLC MGP announced...

S&P Leads Off December with Two Days of Record Highs By Zacks Investment Research - Dec 02, 2020

SPECIAL ALERT: Remember, we need your input to make next week’s new Zacks Ultimate Strategy Session episode the best it can be. There are two ways you can participate:1) Zacks Mailbag: In this...

Hologic's (HOLX) New AI Technology Now Available Post FDA Nod By Zacks Investment Research - Dec 02, 2020

Hologic (NASDAQ:HOLX), Inc. HOLX recently announced the commercial availability of its Genius AI Detection technology post its FDA approval. Notably, the latest technology is a deep-learning-based...

Hewlett Packard (HPE) Q4 Earnings & Revenues Beat Estimates By Zacks Investment Research - Dec 02, 2020

Hewlett Packard Enterprise (NYSE:HPE) Company HPE delivered fourth-quarter fiscal 2020 non-GAAP earnings of 37 cents per share, which surpassed the Zacks Consensus Estimate of 34 cents. However, the...

Acceleron (XLRN) Gets Orphan Drug Tag for ACE-1334 by FDA By Zacks Investment Research - Dec 02, 2020

Acceleron Pharma (NASDAQ:XLRN) Inc. XLRN announced that the FDA granted orphan drug designation to ACE-1334 for the treatment of patients with systemic sclerosis.Shares of the company have surged...

Zscaler (ZS) Q1 Earnings and Revenues Surpass Estimates By Zacks Investment Research - Dec 02, 2020

Zscaler (NASDAQ:ZS) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.03 per share a year ago. These figures...

Roche's (RHHBY) Xolair Gets FDA Nod for Label Expansion By Zacks Investment Research - Dec 02, 2020

Roche RHHBY (OTC:RHHBY) announced that the FDA has approved the label expansion of asthma drug, Xolair.The agency approved the company’s supplemental Biologics License Application (sBLA) for...

Continue with Apple
Continue with Google
or
Sign up with Email